Grigory Berezkin built his career on a single recurring idea: spot an open niche in a transitioning industry, build partnerships with the best teams the global market has to offer and turn an ...

Swiss pharma heavyweight Novartis is cutting a very large check. The company has agreed to acquire London-headquartered ...

Novartis will pay $1.1bn upfront and up to $400m in milestones for Myricx Bio, a UK firm developing a novel payload for antibody-drug conjugates.

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...

Brandon Capital, Australasia’s leading life sciences venture capital firm, today announces the successful exit of its ...

Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...

King Abdulaziz City for Science and Technology (KACST) today celebrated Professor Omar Yaghi, winner of the 2025 Nobel Prize ...

Gary Gregg II can’t avoid George Washington. For him, a political scientist who wrote his dissertation on the American presidency, Washington looms even larger than he does over ...

Dr. Albert B. Sabin gave away his oral polio vaccine for free, but the first biography on the scientist presents a man of ...

During the convention, Jyong Biotech presented its botanical new drug candidate, Botreso® (API-1), to international pharmaceutical companies as the Company continues advancing global licensing ...

Publisher’s Weekly has spoken. The weekly trade news magazine for publishers, librarians, booksellers and literary agents has ...

Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...